Open AccessA Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5
Author(s) -
Aruba Cham
Publication year - 2015
Publication title -
journal of cancer treatment and research
Language(s) - English
Resource type - Journals
eISSN - 2376-7790
pISSN - 2376-7782
DOI - 10.11648/j.jctr.20150302.12
Subject(s) - bioassay , pharmacology , drug , anticancer drug , medicine , cancer , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom